R-ESHAP Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of rituximab, etoposide, methylprednisolone, high-dose cytarabine and cisplatin that can be used in the treatment of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma.
**Synonyms:** - Cytarabine-Cisplatin-Etoposide-Methylprednisolone-Rituximab - Cytarabine/Cisplatin/Etoposide/Methylprednisolone/Rituxan - Cytarabine/Cisplatin/Etoposide/Methylprednisolone/Rituximab - ESHAP Plus Rituximab - ESHAP-R - Etoposide-Solumedrol-High Dose Ara-C-Platinol-Rituximab Regimen - Etoposide/Methylprednisolone/Cytarabine/Cisplatin Plus Rituximab - Etoposide/Methylprednisolone/High-dose Cytarabine/Cisplatin - Etoposide/Solumedrol/High Dose Ara-C/Platinol/Rituximab Regimen - R-ESHAP - R-ESHAP - R-ESHAP (rituximab-abbs) - R-ESHAP (rituximab-arrx) - R-ESHAP (rituximab-blit) - R-ESHAP (rituximab-pvvr) - R-ESHAP (rituximab-rite) - R-ESHAP (rituximab-rixa) - R-ESHAP (rituximab-rixi) - Rituximab-Etoposide-Methylprednisolone-High-dose Cytarabine-Cisplatin - Rituximab-Etoposide-Solu-Medrol-High-dose Ara-C-Platinol - Rituximab/Etoposide/Solumedrol/High-dose Cytarabine/Cisplatin
/api/v1/systems/nci_thesaurus/nodes/C140099Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.